Skip to main content
SpringerLink
Log in

Herbal nutraceutical treatment of chronic prostatitis–chronic pelvic pain syndrome: a literature review

  • Urology - Review
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is the most frequent form of prostatitis, and has a serious impact on patients’ quality of life, and causes severe symptoms. The pain in the pelvic, perineal and penile areas, lower abdominal pain, and pain during urination or ejaculation are the main complaints of CP/CPPS. The underlying complex and unknown pathophysiology of this syndrome have made the management of CP/CPPS and the availability of monotherapy challenging. To identify an effective monotherapy, a plethora of clinical trials failed due to its puzzling etiology. Antibiotics, anti-inflammatory, and a-blockers have been commonly used for the treatment of CP/CPPS, but the desired and complete effects have not been gotten yet. The patients and clinicians are attracted to alternative therapies because of their multi-targeted effects. Attention toward natural compounds effectiveness and safety, supporting the development of a new nutraceutical science. In the alternative remedies for the treatment of prostatic diseases, medicinal herbs, in the form of herb parts or extracts, are getting attention due to their positive effects on prostatic diseases. At present, there is no available detailed literature review about the efficacy of medicinal herbs in the treatment of CP/CPPS. This review aimed to explore the useful medicinal herbs in the treatment of CP/CPPS from different perspectives and their possible mechanism of action in managing CP/CPPS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Clemens JQ, Meenan RT, O’Keeffe Rosetti MC, Kimes T, Calhoun EA (2007) Prevalence of and risk factors for prostatitis: population based assessment using physician assigned diagnoses. J Urol 178(4 Pt 1):1333–1337. https://doi.org/10.1016/j.juro.2007.05.140

    Article  PubMed  Google Scholar 

  2. Khan FU, Ihsan AU, Khan HU, Jana R, Wazir J, Khongorzul P, Waqar M, Zhou X (2017) Comprehensive overview of prostatitis. Biomed Pharmacother 94:1064–1076

    Article  PubMed  Google Scholar 

  3. Schaeffer AJ, Datta NS, Fowler JE Jr, Krieger JN, Litwin MS, Nadler RB, Nickel JC, Pontari MA, Shoskes DA, Zeitlin SI (2002) Overview summary statement. Elsevier

    Book  Google Scholar 

  4. Walz J, Perrotte P, Hutterer G, Suardi N, Jeldres C, Bénard F, Valiquette L, Karakiewicz PI (2007) Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men. BJU Int 100(6):1307–1311

    Article  PubMed  Google Scholar 

  5. Strauss AC, Dimitrakov JD (2010) New treatments for chronic prostatitis/chronic pelvic pain syndrome. Nat Rev Urol 7(3):127–135

    Article  PubMed  PubMed Central  Google Scholar 

  6. Rees J, Abrahams M, Doble A, Cooper A, Group PER (2015) Diagnosis and treatment of chronic bacterial prostatitis and chronic prostatitis/chronic pelvic pain syndrome: a consensus guideline. BJU Int 116(4):509–525

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Zhang K, Bai W-J, Shang X-J, Xiao Y-X, Liu J-H, Li Z, Deng C-H, Wang H-P (2013) Application of CUA guidelines on prostatitis in the management of chronic pelvic pain syndrome: a nationwide survey. Zhonghua nan ke xue = Natl J Androl 19(2):127–131

    Google Scholar 

  8. Engeler DS, Baranowski AP, Dinis-Oliveira P, Elneil S, Hughes J, Messelink EJ, van Ophoven A, Williams AC (2013) The 2013 EAU guidelines on chronic pelvic pain: is management of chronic pelvic pain a habit, a philosophy, or a science? 10 years of development. Eur Urol 64(3):431–439

    Article  PubMed  Google Scholar 

  9. Hu M, Wazir J, Ullah R, Wang W, Cui X, Tang M, Zhou X (2019) Phytotherapy and physical therapy in the management of chronic prostatitis–chronic pelvic pain syndrome. Int Urol Nephrol 51(7):1081–1088

    Article  CAS  PubMed  Google Scholar 

  10. Wazir J, Ullah R, Khongorzul P, Hossain MA, Khan MW, Aktar N, Cui X, Zhou X (2021) The effectiveness of Hedyotis diffusa Willd extract in a mouse model of experimental autoimmune prostatitis. Andrologia 53(1):e13913

    Article  CAS  PubMed  Google Scholar 

  11. Yarnell E, Abascal K (2005) Natural approaches to treating chronic prostatitis and chronic pelvic pain syndromes. Altern Complement Ther 11(5):246–251

    Article  Google Scholar 

  12. Falzon CC, Balabanova A (2017) Phytotherapy: an introduction to herbal medicine. Prim Care Clin Office Pract 44(2):217–227

    Article  Google Scholar 

  13. Colalto C (2018) What phytotherapy needs: evidence-based guidelines for better clinical practice. Phytother Res 32(3):413–425

    Article  PubMed  Google Scholar 

  14. Zaidi N, Thomas D, Chughtai B (2018) Management of chronic prostatitis (CP). Curr Urol Rep 19(11):1–7

    Article  Google Scholar 

  15. Doiron RC, Nickel JC (2018) Management of chronic prostatitis/chronic pelvic pain syndrome. Can Urol Assoc J 12(6 Suppl 3):S161

    Article  PubMed  PubMed Central  Google Scholar 

  16. Arora HC, Eng C, Shoskes DA (2017) Gut microbiome and chronic prostatitis/chronic pelvic pain syndrome. Ann Transl Med 5(2):30. https://doi.org/10.21037/atm.2016.12.32

  17. Magistro G, Nickel JC (2019) Evaluation of chronic prostatitis/chronic pelvic pain syndrome. Version: 2019-02-12. In: Bjerklund Johansen TE, Wagenlehner FME, Matsumoto T, Cho YH, Krieger JN, Shoskes D, Naber KG (eds) Urogenital infections and inflammations, vol 2017. German Medical Science GMS Publishing House, Berlin. https://doi.org/10.5680/lhuii000014

  18. DeWitt-Foy ME, Nickel JC, Shoskes DA (2019) Management of chronic prostatitis/chronic pelvic pain syndrome. Eur Urol Focus 5(1):2–4

    Article  PubMed  Google Scholar 

  19. Wadlow G (1993) Traditional Chinese medicine. Complement Ther Med 1(3):146–147

    Article  Google Scholar 

  20. Zhou J, Xie G, Yan X (2011) Encyclopedia of traditional Chinese medicines. Isolat Compd AB 1:455

    Google Scholar 

  21. Li H, Hung A, Yang AWH (2018) A classic herbal formula Danggui Beimu Kushen Wan for chronic prostatitis: from traditional knowledge to scientific exploration. Evid-Based Complement Altern Med 2018:1–11

    Google Scholar 

  22. Ma W-G, Jia J-M (2011) The effects and prospects of the integration of traditional Chinese medicine and Western medicine on andrology in China. Asian J Androl 13(4):592

    Article  PubMed  PubMed Central  Google Scholar 

  23. Cicero AF, Allkanjari O, Busetto GM, Cai T, Larganà G, Magri V, Perletti G, Della Cuna FSR, Russo GI, Stamatiou K (2019) Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer. Arch Ital Urol Androl. https://doi.org/10.4081/aiua.2019.3.139

    Article  PubMed  Google Scholar 

  24. Bidlack WR, Omaye ST, Meskin MS, Topham DK (2000) Phytochemicals as bioactive agents. CRC Press

    Book  Google Scholar 

  25. Shoskes DA, Manickam K (2003) Herbal and complementary medicine in chronic prostatitis. World J Urol 21(2):109–113

    Article  PubMed  Google Scholar 

  26. Sun Y, Lenon GB, Yang AWH (2019) Phellodendri cortex: a phytochemical, pharmacological, and pharmacokinetic review. Evid Based Complement Alternat Med 2019:7621929. https://doi.org/10.1155/2019/7621929

  27. Zheng Y, Hui R, Hou D (2010) Studies on flavones and anti-oxidation effect of phellodendron. J Anshan Norm Univ 6:16

    Google Scholar 

  28. Xian Y-F, Mao Q-Q, Ip S-P, Lin Z-X, Che C-T (2011) Comparison on the anti-inflammatory effect of cortex Phellodendri chinensis and cortex Phellodendri amurensis in 12-O-tetradecanoyl-phorbol-13-acetate-induced ear edema in mice. J Ethnopharmacol 137(3):1425–1430

    Article  PubMed  Google Scholar 

  29. Ryuk JA, Zheng MS, Lee MY, Seo CS, Li Y, Lee SH, Moon DC, Lee HW, Lee J-H, Park JY (2012) Discrimination of Phellodendron amurense and P. chinense based on DNA analysis and the simultaneous analysis of alkaloids. Arch Pharm Res 35(6):1045–1054

    Article  CAS  PubMed  Google Scholar 

  30. Jiang QJ, Chen W, Dan H, Tan L, Zhu H, Yang G, Shen J, Peng YB, Zhao P, Xue L, Yu MF, Ma L, Si XT, Wang Z, Dai J, Qin G, Zou C, Liu QH (2016) Cortex phellodendri extract relaxes airway smooth muscle. Evid Based Complement Alternat Med 2016:8703239. https://doi.org/10.1155/2016/8703239

  31. Cao X, Sun L, Li D, You G, Wang M, Ren X (2018) Quality evaluation of phellodendri chinensis cortex by fingerprint–chemical pattern recognition. Molecules 23(9):2307

    Article  PubMed Central  CAS  Google Scholar 

  32. Wang L, Wang X, Zhu X-M, Liu Y-Q, Du W-J, Ji J, He X, Zhang C-F, Li F, Guo C-R (2017) Gastroprotective effect of alkaloids from cortex phellodendri on gastric ulcers in rats through neurohumoral regulation. Planta Med 83(03/04):277–284

    CAS  PubMed  Google Scholar 

  33. Fujii A, Okuyama T, Wakame K, Okumura T, Ikeya Y, Nishizawa M (2017) Identification of anti-inflammatory constituents in Phellodendri cortex and Coptidis rhizoma by monitoring the suppression of nitric oxide production. J Nat Med 71(4):745–756

    Article  CAS  PubMed  Google Scholar 

  34. Park Y-k, Chung YS, Kim YS, Kwon O-Y, Joh TH (2007) Inhibition of gene expression and production of iNOS and TNF-α in LPS-stimulated microglia by methanol extract of Phellodendri cortex. Int Immunopharmacol 7(7):955–962

    Article  CAS  PubMed  Google Scholar 

  35. Nadler RB, Koch AE, Calhoun EA, Campbell PL, Pruden DL, Bennett CL, Yarnold PR, Schaeffer AJ (2000) IL-1β and TNF-α in prostatic secretions are indicators in the evaluation of men with chronic prostatitis. J Urol 164(1):214–218

    Article  CAS  PubMed  Google Scholar 

  36. Lu C-F, Meng X-H, Li H-B, Wu H, Dou Z-L (2015) Effect of phellodendron chinense extract on carrageenan-induced chronic prostatitis in rats. Trop J Pharm Res 14(2):257–262

    Article  Google Scholar 

  37. Leask A, Abraham DJ (2004) TGF-β signaling and the fibrotic response. FASEB J 18(7):816–827

    Article  CAS  PubMed  Google Scholar 

  38. Sun H, Wang H, Zhang A, Wang X (eds) (2015) Chapter 21 - Metabolic biomarkers of nonbacterial prostatitis, and the treatment evaluation of phellodendri amurensis cortex and its main components. Academic Press, Chinmedomics, pp 327–346. https://doi.org/10.1016/B978-0-12-803117-9.00021-4

  39. Yesilada E, Küpeli E (2007) Clematis vitalba L. aerial part exhibits potent anti-inflammatory, antinociceptive and antipyretic effects. J Ethnopharmacol 110(3):504–515

    Article  PubMed  Google Scholar 

  40. Song ZH, Zhao YY, Duan JL, Wang X (1995) Review of chemical consituents and pharmacological actions of Chematis species. Nat Prod Res Dev 2:66–72

    Google Scholar 

  41. Chen R, Cui L, Guo Y, Rong Y, Lu X, Sun M, Zhang L, Tian J (2011) In vivo study of four preparative extracts of Clematis terniflora DC. for antinociceptive activity and anti-inflammatory activity in rat model of carrageenan-induced chronic non-bacterial prostatitis. J Ethnopharmacol 134(3):1018–1023

    Article  CAS  PubMed  Google Scholar 

  42. Chawla R, Kumar S, Sharma A (2012) The genus Clematis (Ranunculaceae): chemical and pharmacological perspectives. J Ethnopharmacol 143(1):116–150

    Article  CAS  PubMed  Google Scholar 

  43. Zhang L, Luo X, Tian J (2007) Chemical constituents from Clematis terniflora. Chem Nat Compd 43(2):128–131

    Article  Google Scholar 

  44. Suh S-J, Kim K-S, Lee S-D, Lee CH, Choi HS, Jin U-H, Chang Y-C, Kim C-H (2006) Effects and mechanisms of Clematis mandshurica Maxim. as a dual inhibitor of proinflammatory cytokines on adjuvant arthritis in rats. Environ Toxicol Pharmacol 22(2):205–212

    Article  CAS  PubMed  Google Scholar 

  45. Li RW, Lin GD, Myers SP, Leach DN (2003) Anti-inflammatory activity of Chinese medicinal vine plants. J Ethnopharmacol 85(1):61–67

    Article  PubMed  Google Scholar 

  46. Mostafa M, Appidi JR, Yakubu MT, Afolayan AJ (2010) Anti-inflammatory, antinociceptive and antipyretic properties of the aqueous extract of Clematis brachiata leaf in male rats. Pharm Biol 48(6):682–689

    Article  CAS  PubMed  Google Scholar 

  47. Lee SW, Chung WT, Choi SM, Kim KT, Yoo KS, Yoo YH (2005) Clematis mandshurica protected to apoptosis of rat chondrocytes. J Ethnopharmacol 101(1–3):294–298

    Article  PubMed  Google Scholar 

  48. Peng H, Lv H, Wang Y, Liu Y-h, Li C-y, Meng L, Chen F, Bao J-k (2009) Clematis montana lectin, a novel mannose-binding lectin from traditional Chinese medicine with antiviral and apoptosis-inducing activities. Peptides 30(10):1805–1815

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Noh Y, Cheon S, Kim IH, Kim I, Lee S-A, Kim D-H, Jeong Y (2018) The protective effects of ethanolic extract of Clematis terniflora against corticosterone-induced neuronal damage via the AKT and ERK1/2 pathway. BMB Rep 51(8):400

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Liu X, Yang B, Zhang L, Lu Y, Gong M, Tian J (2015) An in vivo and in vitro assessment of the anti-inflammatory, antinociceptive, and immunomodulatory activities of Clematis terniflora DC. extract, participation of aurantiamide acetate. J Ethnopharmacol 169:287–294

    Article  CAS  PubMed  Google Scholar 

  51. Liu Xiaobao RY, Yan Xu, Li R, Zhang L, Zhang Y, Tian J (2012) Experimental study of ethanol extract of Clematis terniflora DC. on non-bacterial prostatitis in rats. Chin J Mod Appl Pharm 29(05):381–385

    Google Scholar 

  52. Ling-lan T, Xiao-liang Z, Li-yan C, Dong-mei Y, Gao-li Z (2014) Protective effects of Clematis terniflora DC on chronic abacterial prostatitis in rats and its mechanism. Nat Prod Res Dev 26(11):1761

    Google Scholar 

  53. China PC (2000) Pharmacopoeia of the People’s Republic of China. Chemical Industry Press

    Google Scholar 

  54. Fernández M (1981) Las plantas en la medicina popular navarra 1. Navarra húmeda del NO Pamplona Sociedad de Estudios Vascos-Eusko Ikaskuntza

  55. Müller A, Ganzera M, Stuppner H (2004) Analysis of the aerial parts of Verbena officinalis L. by micellar electrokinetic capillary chromatography. Chromatographia 60(3–4):193–197

    Google Scholar 

  56. Deepak M, Handa SS (2000) Antiinflammatory activity and chemical composition of extracts of Verbena officinalis. Phytother Res 14(6):463–465

    Article  CAS  PubMed  Google Scholar 

  57. Calvo M, Vilalta N, San Julián A, Fernández M (1998) Anti-inflammatory activity of leaf extract of Verbena officinalis L. Phytomedicine 5(6):465–467

    Article  CAS  PubMed  Google Scholar 

  58. Calvo M (2006) Anti-inflammatory and analgesic activity of the topical preparation of Verbena officinalis L. J Ethnopharmacol 107(3):380–382

    Article  CAS  PubMed  Google Scholar 

  59. Akour A, Kasabri V, Afifi FU, Bulatova N (2016) The use of medicinal herbs in gynecological and pregnancy-related disorders by Jordanian women: a review of folkloric practice vs. evidence-based pharmacology. Pharm Biol 54(9):1901–1918

    Article  PubMed  Google Scholar 

  60. Liu Z, Xu Z, Zhou H, Cao G, Cong X-D, Zhang Y, Cai B-C (2012) Simultaneous determination of four bioactive compounds in Verbena officinalis L. by using high-performance liquid chromatography. Pharm Mag 8(30):162

    Article  CAS  Google Scholar 

  61. Wang L, Wang C, Miao M (2016) Effects of total glucosides of Verbena officinalis on chronic nonbacterial prostatitis in mice and its an-ti-inflammatory and analgesic effects study. China Pharm 27(19):2608–2611

    Google Scholar 

  62. Miao M, Guo L, Yan X, Wang T, Li Z (2016) Effects of verbenalin on prostatitis mouse model. Saudi J Biol Sci 23(1):S148-157. https://doi.org/10.1016/j.sjbs.2015.10.006

    Article  CAS  PubMed  Google Scholar 

  63. Chen D-Q, Feng Y-L, Tian T, Chen H, Yin L, Zhao Y-Y, Lin R-C (2014) Diuretic and anti-diuretic activities of fractions of Alismatis rhizoma. J Ethnopharmacol 157(114):118

    Google Scholar 

  64. Qin J, Wang Y, Liang J, Zhang Y, Wang S, Guo W (2007) Effect of Alismaceae on regulating the expression of liver basal membrane heparan sulfate proteoglycan in ApoE-knock out atherosclerosis mice. Chin Arch Tradit Chin Med 25:696–698

    Google Scholar 

  65. Mia Q, Cao Z, Liu J (2005) Effects of active fraction of Alisma orientale on osteopontin expression in renal tissue of urolithiasis model rat with calcium oxalate stone. Chin Tradit Herb Drugs 36(12):1827

    Google Scholar 

  66. Han CW, Kwun MJ, Kim KH, Choi J-Y, Oh S-R, Ahn K-S, Lee JH, Joo M (2013) Ethanol extract of Alismatis Rhizoma reduces acute lung inflammation by suppressing NF-κB and activating Nrf2. J Ethnopharmacol 146(1):402–410

    Article  CAS  PubMed  Google Scholar 

  67. Ahn YM, Cho KW, Kang DG, Lee HS (2012) Oryeongsan (Wulingsan), a traditional Chinese herbal medicine, induces natriuresis and diuresis along with an inhibition of the renin–angiotensin–aldosterone system in rats. J Ethnopharmacol 141(3):780–785

    Article  PubMed  Google Scholar 

  68. Ahn Y-M, Kho JH, Lee J-Y, Kang D-G (2012) Oryeongsan has different effects on water and electrolyte balance by routes of administration. Korean J Orient Physiol Pathol 26:338–343

    Google Scholar 

  69. Grieve M, Leyel C (1984) A modern herbal. Penguin, Harmondsworth

    Google Scholar 

  70. Hunan Zhong YYYJS, Geu WH (1974) A barefoot doctor’s manual: the American translation of the official Chinese paramedical manual, No.695, vol 75. Running Press Book Publishers

    Google Scholar 

  71. Yeung H-C (1995) Handbook of Chinese herbs and formulas. Institute of Chinese Medicine

    Google Scholar 

  72. Adams M, Gschwind S, Zimmermann S, Kaiser M, Hamburger M (2011) Renaissance remedies: antiplasmodial protostane triterpenoids from Alisma plantago-aquatica L. (Alismataceae). J Ethnopharmacol 135(1):43–47

    Article  CAS  PubMed  Google Scholar 

  73. Jin Q, Zhang J, Hou J, Lei M, Liu C, Wang X, Huang Y, Yao S, Hwang BY, Wu W (2019) Novel C-17 spirost protostane-type triterpenoids from Alisma plantago-aquatica with anti-inflammatory activity in Caco-2 cells. Acta Pharm Sinica B 9(4):809–818

    Article  Google Scholar 

  74. Huang Y-s, Yu Q-q, Chen Y, Cheng M-j, Xie L-p (2017) Phenolic constituents from Alisma plantago-aquatica Linnaeus and their anti-chronic prostatitis activity. Chem Cent J 11(1):1–5

    Article  CAS  Google Scholar 

  75. Wang X-m, Wang D-d, Wu Y-z, Sun G, Xu Y (2017) Effect of Alisma plantago-aquatica Linn extract on chronic prostatitis in rats. Trop J Pharm Res 16(5):1091–1095

    Article  CAS  Google Scholar 

  76. Editorial Board of China Herba (1998) China herbal. Shanghai Scientific and Technical Publishers, Shanghai

    Google Scholar 

  77. Hori K, Satake T, Saiki Y, Murakami T, Chen C (1987) Chemical and chemotaxonomical studies of filices. 69. The novel coumarins of macrothelypteris-torresiana ching var calvata holtt (= m-oligophlebia ching). Yakugaku Zasshi-J Pharm Soc Japan 107(7):491–494

    Article  CAS  Google Scholar 

  78. Wu G, Cai Y, Wei H, Wei A, Xiong C, Fu W, Ruan J (2012) Nephroprotective activity of Macrothelypteris oligophlebia rhizomes ethanol extract. Pharm Biol 50(6):773–777

    Article  PubMed  Google Scholar 

  79. Han P, Lai Y, Ruan J, Deng A, Wang Y (2015) Study on active fractions of Macrothelypteris oligophlebia for chronic non-bacterial prostatitis in rats. China Pharm 18(10):1645–1648

    Google Scholar 

  80. Han P, Lai YJ, Chen J, Zhang XN, Chen JL, Yang X, Xue PP, Ruan JL (2016) Protective potential of the methanol extract of Macrothelypteris oligophlebia rhizomes for chronic non-bacterial prostatitis in rats. Pak J Pharm Sci 29(4):1217–1221

  81. Labban L (2014) Medicinal and pharmacological properties of turmeric (Curcuma longa): a review. Int J Pharm Biomed Sci 5(1):17–23

    Google Scholar 

  82. Goel A, Kunnumakkara AB, Aggarwal BB (2008) Curcumin as “Curecumin”: from kitchen to clinic. Biochem Pharmacol 75(4):787–809

    Article  CAS  PubMed  Google Scholar 

  83. Lawand RV, Gandhi SV (2013) Comparison of Curcuma caesia Roxb. with other commonly used Curcuma species by HPTLC. J Pharm Phytochem 2(4):126–131

    Google Scholar 

  84. Funk JL, Frye JB, Oyarzo JN, Kuscuoglu N, Wilson J, McCaffrey G, Stafford G, Chen G, Lantz RC, Jolad SD (2006) Efficacy and mechanism of action of turmeric supplements in the treatment of experimental arthritis. Arthritis Rheum 54(11):3452–3464

    Article  CAS  PubMed  Google Scholar 

  85. Julie S, Jurenka M (2009) Anti-inflammatory properties of curcumin, a major constituent. Altern Med Rev 14(2):141–153

    Google Scholar 

  86. Anand P, Nair HB, Sung B, Kunnumakkara AB, Yadav VR, Tekmal RR, Aggarwal BB (2010) RETRACTED: design of curcumin-loaded PLGA nanoparticles formulation with enhanced cellular uptake, and increased bioactivity in vitro and superior bioavailability in vivo. Elsevier

    Google Scholar 

  87. Aggarwal BB, Sung B (2009) Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 30(2):85–94

    Article  CAS  PubMed  Google Scholar 

  88. Shu L, Khor TO, Lee J-H, Boyanapalli SS, Huang Y, Wu T-Y, Saw CL-L, Cheung K-L, Kong A-NT (2011) Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells. AAPS J 13(4):606–614

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Zhang Q-Y, Mo Z-N, Liu X-D (2010) Reducing effect of curcumin on expressions of TNF-alpha, IL-6 and IL-8 in rats with chronic nonbacterial prostatitis. Zhonghua Nan Ke Xue = Natl J Androl 16(1):84–88

    CAS  Google Scholar 

  90. Morgia G, Russo GI, Urzì D, Privitera S, Castelli T, Favilla V, Cimino S (2017) A phase II, randomized, single-blinded, placebo-controlled clinical trial on the efficacy of curcumina and calendula suppositories for the treatment of patients with chronic prostatitis/chronic pelvic pain syndrome type III. Arch Ital Urol Androl 89(2):110–113

    Article  CAS  PubMed  Google Scholar 

  91. Oloyede F (2012) Growth, yield and antioxidant profile of pumpkin (Cucurbita pepo L.) leafy vegetable as affected by NPK compound fertilizer. J Soil Sci Plant Nutr 12(3):379–388

    Google Scholar 

  92. Smith BD (1997) The initial domestication of Cucurbita pepo in the Americas 10,000 years ago. Science 276(5314):932–934

    Article  CAS  Google Scholar 

  93. Li J (2007) Flora of China. Harv Pap Bot 13(2):301–302

    Article  Google Scholar 

  94. Gutierrez RP (2016) Review of Cucurbita pepo (pumpkin) its phytochemistry and pharmacology. Med Chem 6:12–21

    CAS  Google Scholar 

  95. Adebayo O, Farombi A, Oyekanmi A (2013) Proximate, mineral and anti-nutrient evaluation of pumpkin pulp (Cucurbita pepo). J Appl Chem 4(4):25–28

    Google Scholar 

  96. Caili F, Huan S, Quanhong L (2006) A review on pharmacological activities and utilization technologies of pumpkin. Plant Foods Hum Nutr 61(2):70–77

    Article  CAS  Google Scholar 

  97. Yadav M, Jain S, Tomar R, Prasad G, Yadav H (2010) Medicinal and biological potential of pumpkin: an updated review. Nutr Res Rev 23(2):184–190

    Article  CAS  PubMed  Google Scholar 

  98. Ullah R, Wazir J, Hossain MA, Diallo MT, Khan FU, Ihsan AU, Zhou X (2020) A glimpse into the efficacy of alternative therapies in the management of benign prostatic hyperplasia. Wien Klin Wochenschr 133:153–162

    Article  PubMed  Google Scholar 

  99. Hong H, Kim C-S, Maeng S (2009) Effects of pumpkin seed oil and saw palmetto oil in Korean men with symptomatic benign prostatic hyperplasia. Nurs Res Pract 3(4):323–327

    Google Scholar 

  100. Abdel-Rahman MK (2006) Effect of pumpkin seed (Cucurbita pepo L.) diets on benign prostatic hyperplasia (BPH): chemical and morphometric evaluation in rats. World J Chem 1(1):33–40

    Google Scholar 

  101. Rathinavelu A, Levy A, Sivanesan D, Murugan D, Jornadal J, Quinonez Y, Jaffe M, Gossell-Williams M (2013) Cytotoxic effect of pumpkin (Curcurbita pepo) seed extracts in LNCaP prostate cancer cells is mediated through apoptosis. Curr Topics Nutraceuticals Res 11(4):137

    Google Scholar 

  102. Tantawy SA, Elgohary HM, Kamel DM (2018) Trans-perineal pumpkin seed oil phonophoresis as an adjunctive treatment for chronic nonbacterial prostatitis. Res Rep Urol 10:95

    CAS  PubMed  PubMed Central  Google Scholar 

  103. Commission CP (2010) Pharmacopoeia of the People’s Republic of China. Volume I. China Press Med Sci Technol 49

  104. Gong AG, Duan R, Wang HY, Kong XP, Dong TT, Tsim KW, Chan K (2018) Evaluation of the pharmaceutical properties and value of Astragali radix. Medicines 5(2):46

    Article  PubMed Central  CAS  Google Scholar 

  105. Zhang L, Gong AG, Riaz K, Deng JY, Ho CM, Lin HQ, Dong TT, Lee YK, Tsim KW (2017) A novel combination of four flavonoids derived from Astragali radix relieves the symptoms of cyclophosphamide-induced anemic rats. FEBS Open Bio 7(3):318–323

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. Wu L, Chen Y, Xu Y, Guo X, Li X, Zhang AL, May BH, Xue CC, Wen Z, Lin L (2013) Oral huangqi formulae for stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. Evid-Based Complement Altern Med 2013:705315. https://doi.org/10.1155/2013/705315

  107. Yu J, Ji H-y, Liu A-j (2018) Alcohol-soluble polysaccharide from Astragalus membranaceus: preparation, characteristics and antitumor activity. Int J Biol Macromol 118:2057–2064

    Article  CAS  PubMed  Google Scholar 

  108. Hu X-J (2019) Protective capability of Astragalus (Huangqi) on auditory function in a rat model of estrogen deficiency. Chin Med J 132(1):106

    Article  PubMed  PubMed Central  Google Scholar 

  109. Fu J, Wang Z, Huang L, Zheng S, Wang D, Chen S, Zhang H, Yang S (2014) Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi). Phytother Res 28(9):1275–1283

    Article  CAS  PubMed  Google Scholar 

  110. Lee YS, Han OK, Park CW, Yang CH, Jeon TW, Yoo WK, Kim SH, Kim HJ (2005) Pro-inflammatory cytokine gene expression and nitric oxide regulation of aqueous extracted Astragali radix in RAW 2647 macrophage cells. J Ethnopharmacol 100(3):289–294

    Article  PubMed  Google Scholar 

  111. Qin Q, Niu J, Wang Z, Xu W, Qiao Z, Gu Y (2012) Astragalus membranaceus inhibits inflammation via phospho-P38 mitogen-activated protein kinase (MAPK) and nuclear factor (NF)-κB pathways in advanced glycation end product-stimulated macrophages. Int J Mol Sci 13(7):8379–8387

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  112. Kang H, Ahn K-S, Cho C, Bae H-S (2004) Immunomodulatory effect of Astragali radix extract on murine TH1/TH2 cell lineage development. Biol Pharm Bull 27(12):1946–1950

    Article  CAS  PubMed  Google Scholar 

  113. M-x LUO, G-t LIN (2018) Study on the inhibitory effects of different solvent extracts from Astragali radix on prostatic hyperplasia. Shandong Sci 3:4

    Google Scholar 

  114. Zhang K, Zeng X, Chen Y, Zhao R, Wang H, Wu J (2017) Therapeutic effects of Qian-Yu decoction and its three extracts on carrageenan-induced chronic prostatitis/chronic pelvic pain syndrome in rats. BMC Complement Altern Med 17(1):1–11

    Article  CAS  Google Scholar 

  115. Hu RY, Wei BL (2015) Effect and mechanism of astragali radix extract on chronic nonbacterial prostatitis in rats. Chin J Exp Tradit Med Formulae 21(13):152–155

  116. Guo R (2005) The healing power of chinese herbs and medicinal recipes. Focus Altern Complement Ther 10:336–337. https://doi.org/10.1111/j.2042-7166.2005.tb00435.x

  117. Zhao H, Wang Q, Sun Y, Yang B, Wang Z, Chai G, Guan Y, Zhu W, Shu Z, Lei X (2014) Purification, characterization and immunomodulatory effects of Plantago depressa polysaccharides. Carbohyd Polym 112:63–72

    Article  CAS  Google Scholar 

  118. Han N, Wang L, Song Z, Lin J, Ye C, Liu Z, Yin J (2016) Optimization and antioxidant activity of polysaccharides from Plantago depressa. Int J Biol Macromol 93:644–654

    Article  CAS  PubMed  Google Scholar 

  119. Xia N, Li B-a, Liu H-j, Fan J-b, Shen W, He X-g (2017) Anti-hyperuricemic effect of Plantago depressa Willd extract in rats. Trop J Pharm Res 16(6):1365–1368

    Article  CAS  Google Scholar 

  120. Ay N, Kh A, Enkhchimeg V, Baatartsogt O (2017) Anticancer effect of plantago depressa ethanolic extract in B16F10 skin cancer cells. Mong J Agric Sci 21(02):29–34

    Article  Google Scholar 

  121. Li M, Cao W (2016) Effect of Plantago depressa Willd. extract on chronic nonbacterial prostatitis in rats. Her Med 35(6):592–596

    Google Scholar 

  122. Adamski Z, Blythe LL, Milella L, Bufo SA (2020) Biological activities of alkaloids: from toxicology to pharmacology. Multidisciplinary Digital Publishing Institute

    Google Scholar 

  123. Miao MS, Tian S, Guo L (2014) Effects of motherwort total alkaloids on prostatitis model of rats. Adv Mat Res 926–930:1045–1048

    Google Scholar 

  124. Dai J, Mumper RJ (2010) Plant phenolics: extraction, analysis and their antioxidant and anticancer properties. Molecules 15(10):7313–7352

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  125. Williamson G (2017) The role of polyphenols in modern nutrition. Nutr Bull 42(3):226–235

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  126. Ihsan AU, Khan FU, Khongorzul P, Ahmad KA, Naveed M, Yasmeen S, Cao Y, Taleb A, Maiti R, Akhter F (2018) Role of oxidative stress in pathology of chronic prostatitis/chronic pelvic pain syndrome and male infertility and antioxidants function in ameliorating oxidative stress. Biomed Pharmacother 106:714–723

    Article  CAS  PubMed  Google Scholar 

  127. Karamati SA, Hassanzadazar H, Bahmani M, Rafieian-Kopaei M (2014) Herbal and chemical drugs effective on malaria. Asian Pac Jo Trop Dis 4(S2):S599–S601

    Article  Google Scholar 

  128. Engler MB, Engler MM (2004) The vasculoprotective effects of flavonoid-rich cocoa and chocolate. Nutr Res 24(9):695–706

    Article  CAS  Google Scholar 

  129. Milbury PE (2012) Flavonoid intake and eye health. J Nutr Gerontol Geriatr 31(3):254–268

    Article  PubMed  Google Scholar 

  130. Cai T, Verze P, La Rocca R, Anceschi U, De Nunzio C, Mirone V (2017) The role of flower pollen extract in managing patients affected by chronic prostatitis/chronic pelvic pain syndrome: a comprehensive analysis of all published clinical trials. BMC Urol 17(1):1–8

    Article  CAS  Google Scholar 

  131. Cai T, Tiscione D, Gallelli L, Verze P, Palmieri A, Mirone V, Bartoletti R, Malossini G (2016) Serenoa repens associated with selenium and lycopene extract and bromelain and methylsulfonylmethane extract are able to improve the efficacy of levofloxacin in chronic bacterial prostatitis patients. Arch Ital Urol Androl 88(3):177–182

    Article  CAS  PubMed  Google Scholar 

  132. Cai T, Wagenlehner FM, Luciani LG, Tiscione D, Malossini G, Verze P, Mirone V, Bartoletti R (2014) Pollen extract in association with vitamins provides early pain relief in patients affected by chronic prostatitis/chronic pelvic pain syndrome. Exp Ther Med 8(4):1032–1038

    Article  PubMed  PubMed Central  Google Scholar 

  133. Gan D, Tang A, Wu X, Li F (2013) Effect of total flavonoids of Clerodendranthus spicatus on chronic abacterial prostatitis in rats. Chin J Exp Tradit Med Formul 19:266–268

    CAS  Google Scholar 

  134. Guan Q, Zheng Y, Wei X, Wang S, Su B, Yu S (2019) The Effect of flavonoids on chronic prostatitis: a meta-analysis of published randomized controlled trials. J Natl Med Assoc 111(5):555–562

    PubMed  Google Scholar 

  135. Yang A, Ren G, Tang L, Jiang W (2009) Effects of soy bean isoflavone on inhibition of benign prostatic hyperplasia and the expressions of NO and NOS of rats. Wei Sheng Yan Jiu = J Hyg Res 38(2):172–174

    Google Scholar 

  136. Kim H, Peterson TG, Barnes S (1998) Mechanisms of action of the soy isoflavone genistein: emerging role for its effects via transforming growth factor beta signaling pathways. Am J Clin Nutr 68(6):1418S-1425S

    Article  CAS  PubMed  Google Scholar 

  137. Bisson J-F, Hidalgo S, Simons R, Verbruggen M (2014) Preventive effects of lignan extract from flax hulls on experimentally induced benign prostate hyperplasia. J Med Food 17(6):650–656

    Article  CAS  PubMed  Google Scholar 

  138. Ren G-Y, Chen C-Y, Chen W-G, Huang Y, Qin L-Q, Chen L-H (2016) The treatment effects of flaxseed-derived secoisolariciresinol diglycoside and its metabolite enterolactone on benign prostatic hyperplasia involve the G protein-coupled estrogen receptor 1. Appl Physiol Nutr Metab 41(12):1303–1310

    Article  CAS  PubMed  Google Scholar 

  139. Ward AB, Mir H, Kapur N, Gales DN, Carriere PP, Singh S (2018) Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways. World J Surg Oncolo 16(1):1–12

    Google Scholar 

  140. Marchiani A, Rozzo C, Fadda A, Delogu G, Ruzza P (2014) Curcumin and curcumin-like molecules: from spice to drugs. Curr Med Chem 21(2):204–222

    Article  CAS  PubMed  Google Scholar 

  141. Wang Y, Tang Q, Duan P, Yang L (2018) Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis. Immunopharmacol Immunotoxicol 40(6):476–482

    Article  CAS  PubMed  Google Scholar 

  142. Marquardt JU, Gomez-Quiroz L, Camacho LOA, Pinna F, Lee Y-H, Kitade M, Domínguez MP, Castven D, Breuhahn K, Conner EA (2015) Curcumin effectively inhibits oncogenic NF-κB signaling and restrains stemness features in liver cancer. J Hepatol 63(3):661–669

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  143. Tsui KH, Feng TH, Lin CM, Chang PL, Juang HH (2008) Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells. J Androl 29(6):661–668

    Article  CAS  PubMed  Google Scholar 

  144. Chung LC, Tsui KH, Feng TH, Lee SL, Chang PL, Juang HH (2011) Curcumin provides potential protection against the activation of hypoxia and prolyl 4-hydroxylase inhibitors on prostate-specific antigen expression in human prostate carcinoma cells. Mol Nutr Food Res 55(11):1666–1676

    Article  CAS  PubMed  Google Scholar 

  145. Cox-Georgian D, Ramadoss N, Dona C, Basu C (2019) Therapeutic and medicinal uses of terpenes. In: Joshee N, Dhekney S, Parajuli P (eds) Medicinal Plants. Springer, pp 333–359

  146. Zhu W-Q, Wang J, Guo X-F, Liu Z, Dong W-G (2016) Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro. World J Gastroenterol 22(16):4149

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  147. Xu D, Ma Y, Zhao B, Li S, Zhang Y, Pan S, Wu Y, Wang J, Wang D, Pan H (2014) Thymoquinone induces G2/M arrest, inactivates PI3K/Akt and nuclear factor-κB pathways in human cholangiocarcinomas both in vitro and in vivo. Oncol Rep 31(5):2063–2070

    Article  CAS  PubMed  Google Scholar 

  148. Cha WH, Kim KH, Seo YJ (2009) Comparison of the efficacy of a terpene mixture and alpha-blocker for treatment of category III chronic prostatitis/chronic pelvic pain syndrome: a prospective study. Korean J Urol 50(2):148–153

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Ochbayasakh Dashdondov and Junaid Wazir contributed equally.

Authors and Affiliations

  1. Department of Clinical Pharmacy, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, Jiangsu Province, China

    Ochbayasakh Dashdondov, Reyaj Mikrani, Nasrin Aktar & Xiaohui Zhou

  2. Center for Translational Medicine and Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing, 210093, People’s Republic of China

    Junaid Wazir

  3. Center for Cancer Genomics, School of Basic Medicine and Clinical Pharmacy, China Pharmaceutical University, Nanjing, 211198, Jiangsu Province, China

    Ganbolor Sukhbaatar

  4. Department of Pharmaceutics, China Pharmaceutical University, Nanjing, 210009, Jiangsu Province, China

    Buyankhishig Dorjsuren

  5. Department of Surgery, Nanjing Shuiximen Hospital, Nanjing, Jiangsu Province, 211198, People’s Republic of China

    Xiaohui Zhou

  6. Zhongda Hospital, Affiliated with Southeast University, Nanjing, 210017, Jiangsu Province, China

    Xiaohui Zhou

Authors
  1. Ochbayasakh Dashdondov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Junaid Wazir
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ganbolor Sukhbaatar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Reyaj Mikrani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Buyankhishig Dorjsuren
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nasrin Aktar
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiaohui Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Xiaohui Zhou.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dashdondov, O., Wazir, J., Sukhbaatar, G. et al. Herbal nutraceutical treatment of chronic prostatitis–chronic pelvic pain syndrome: a literature review. Int Urol Nephrol 53, 1515–1528 (2021). https://doi.org/10.1007/s11255-021-02868-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-021-02868-w

Keywords

Search

Navigation